Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models

Ying Li(Beijing Institute of Technology), Jianqing Gao(Zhejiang University), Jian You(Jinhua Academy of Agricultural Sciences), Meng Wang(Chinese Academy of Sciences), Pei Zhi(Zhejiang University)
Oncotarget
December 8, 2017
Cited by 70


Related Papers